year 12, Issue 1 (March - April 2018)
Iran J Med Microbiol 2018, 12(1): 1-5 |
Back to browse issues page
Professor of Medical Microbiology Health Reference Laboratory, Ministry of Health and Higher Education, Tehran, Iran , masoudhajia@yahoo.com
Abstract: (7245 Views)
Brucellelosis has been almost eradicated in developed countries while in under developed areas from Mediterranean regions to Arabic countries and even in Indian subcontinental can cause serious health problems. This point can be found out easily in released reports. It is over a century that various serological methods have been introduced and applied for diagnosis of brucella infection, but all were not able to provide satisfactory results. Therefore, clinicians treat the patients with various unspecific treatment protocols based on clinical signs and symptoms, consequently causing treatment failure or possible relapse later on. This article aimed to have short survey on serological diagnosis of brucellosis and proposed an approach at present situation of brucellosis diagnostic specifically for local laboratories.
Type of Study: Review Article |
Subject:
Zoonoses Research
Received: 2018/05/14 | Accepted: 2018/05/14 | ePublished: 2018/05/14
Received: 2018/05/14 | Accepted: 2018/05/14 | ePublished: 2018/05/14
References
1. Hajia M, Rahbar M, Keramat F. Epidemiological, clinical, diagnostic and treatment aspects of hospitalized brucellosis patients in Hamadan. Ann Trop Med Public Health. 2009; 2(2):42-5.
2. Pakzad R, Pakzad I, Safiri S, Shirzadi MR, Mohammadpour M, Behroozi A (et al.). Spatiotemporal analysis of brucellosis incidence in Iran from 2011 to 2014 using GIS. International Journal of Infectious Diseases. 2018;67:129–36. [DOI] [PubMed]
3. Eales KM, Norton RE, Ketheesan N. Short Report: Brucellosis in Northern Australi. Am J Trop Med Hyg. 2010;83(4):876-8. [DOI] [PubMed]
4. Hajia M. , Keramat F. Study On the rate of Brucellosis relaps efficiency Different Treatment Protocols in among Hospitalized Patient in Educational Hospital of Hamadan. J Mil Med 2003;5(3):195-9.
5. Abdel-Maksoud M, Hose B, Wasfy M, Abdel Rahman B. In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance. Annals of Clinical Microbiology and Antimicrobials. 2012;11:24. [DOI] [PubMed]
6. Taghvaee MR, Nozadi MS, Hassani M. A Comparison Between Doxycycline-Refampin and Ciprofloxacin-Rifampin Regimes in Treatment of Acute Brucellosis. Indian Journal of Medical Sciences. 2011;65(11):436-47. [PubMed]
7. Hashemi SH, Gachkar L, Keramat F, Mamani M, Hajilooi M, Janbakhsh A (et al.). Comparison of doxycycline–streptomycin, doxycycline–rifampin, and ofloxacin–rifampin in the treatment of brucellosis: a randomized clinical trial. International Journal of Infectious Diseases. 2012;16:e247-51. [DOI] [PubMed]
8. Hajia M, Rahbar M, Taghavi HA. Brucellosis Antibody Level of Hospitalized Patients in Hamadan, Western Iran. Shiraz E-Medical Journal. 2007;8(3):1-5.
9. Franco MP, Mulder M, Gilman R, Smits HL. Human Brucellosis. Lancet Infect Dis. 2007;7:775–86. [DOI]
10. Nielsen K, Smith P, Widdison J, et al. Serological relationship between cattle exposed to Brucella abortus, Yersinia enterocolitica O:9 and Escherichia coli O157:H7. Vet Microbiol. 2004;100:25–30. [DOI] [PubMed]
11. Perry MB, Bundle DR. Lipopolysaccharide antigens and carbohydrates of Brucella. In: Adams LG, editor. Advances in brucellosis research. Austin, Texas A and M University; 1990. p. 76-88.
12. Memish Z, Mah MW, Suliman AM, Shaalan M, Khan Y. Brucella Bacteraemia: Clinical and Laboratory Observations in 160 Patients. Journal of Infection. 2000;40:59–63. [DOI]
13. Zoghi E, Samar G. Interpretation of brucellosis serology tests [in Persian]. Nabz J. 1996;6:30Y34
14. Hajia M, Fallah F, Angoti G, Karimi A, Rahbar M, Gachkar L, et al. Comparison of methods for diagnosing Brucellosis. Lab Med. 2013; 44(1):29-33. [DOI]
15. 15- Christopher S, Umapathy BL, Ravikumar KL. Brucellosis: review on the recent trends in pathogenicity and laboratory diagnosis. Journal of laboratory physicians. 2010;2(2):55–60. [DOI] [PubMed]
16. Hajia M, Sohrabi A. Molecular Diagnostic Methods of Brucellosis: a Note on Pitfalls. Iran J Path. 2018…. [PubMed]
17. Amirzargar A, Hassibi M, Maleknejad P, Hajia M, et al. Comparison of diagnostic methods in hospitalized patients with brucellosis in Iran. Inf Dis Clin Pract. 2009;17(4):239-42. [DOI]
18. Hajia M, Rahbar M. Isolation of Brucella from blood culture of hospitalized brucellosis patients. Iranian J Clin Infect Dis. 2006;1(2):5-10.
19. Golshani M, Buozari S. A Review of Brucellosis in Iran: Epidemiology, Risk Factors, Diagnosis, Control, and Prevention. Iranian Biomedical Journal. 2017;21(6):349-59. [PubMed]
20. Mantur BG, Amarnath, Shinde RS. Review of Clinical and Laboratory features of human brucellosis. Indian J Med Microbiol 2007;25:188-202. [DOI]
21. Chegini AS, Ezatpour B, Saki M, Mokhayeri H, Adavi S, Nasiri E, Azami M. Seroepidemiology of human brucellosis in nomads in a rural area of Iran. Asian Pacific Journal of Tropical Disease. 2014;4(4):333-6. [DOI]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |